Finance

Beta
Lists
SLXNW:NASDAQ
Silexion Therapeutics Corp
$0.030
+1.00%
(+0.00030) 1D
Jun 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLXNW...
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
2.71M
Avg. vol.
63.71K
Volume
0.00
52-wk high
$0.15
52-wk low
$0.01
Beta
-0.93
No. of employees
14
Open
$0.03
High
$0.03
Low
$0.03
Mkt. cap
2.71M
Avg. vol.
63.71K
Volume
0.00
52-wk high
$0.15
52-wk low
$0.01
Beta
-0.93
No. of employees
14
News stories
From sources across the web
About Silexion Therapeutics Corp
CEO-
Employees14
Founded2008
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
2.16M
3.38M
1.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.14M
1.03M
1.38M
Operating expense
-
3.29M
4.41M
2.75M
Total operating expenses
-
3.29M
4.41M
2.75M
Operating income
-
-3.29M
-4.41M
-2.75M
Other non operating income
-
23.00K
-35.00K
11.00K
EBT including unusual items
-
-3.26M
-4.41M
-2.73M
EBT excluding unusual items
-
-3.26M
-4.41M
-2.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-3.26M
-4.41M
-2.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
39.00K
69.00K
32.00K
Interest expense
-
-
-
-
Net interest expenses
-
39.00K
69.00K
32.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-3.29M
-4.40M
-2.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more